BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25227797)

  • 1. Fatty acid synthesis pathway genetic variants and clinical outcome of non-small cell lung cancer patients after surgery.
    Jin X; Zhang KJ; Guo X; Myers R; Ye Z; Zhang ZP; Li XF; Yang HS; Xing JL
    Asian Pac J Cancer Prev; 2014; 15(17):7097-103. PubMed ID: 25227797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in genes of the de novo lipogenesis pathway and overall survival of hepatocellular carcinoma patients undergoing transarterial chemoembolization.
    Wu YS; Bao DK; Dai JY; Chen C; Zhang HX; Yang Y; Xing JL; Huang XJ; Wan SG
    Asian Pac J Cancer Prev; 2015; 16(3):1051-6. PubMed ID: 25735330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variants in de novo lipogenic pathway genes predict the prognosis of surgically-treated hepatocellular carcinoma.
    Jiang H; Dai J; Huang X; Chen Y; Qu P; Li J; Yi C; Yang Y; Zhang K; Huang Q
    Sci Rep; 2015 Mar; 5():9536. PubMed ID: 25826294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional polymorphisms of ATP citrate lyase gene predicts clinical outcome of patients with advanced colorectal cancer.
    Xie S; Zhou F; Wang J; Cao H; Chen Y; Liu X; Zhang Z; Dai J; He X
    World J Surg Oncol; 2015 Feb; 13():42. PubMed ID: 25890184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants in
    He Y; Wang G; Wang Q; Zhao Z; Gan L; Yang S; Wang Y; Guo S; An J; Zhang J; Zhang Z; Zhou F
    Future Oncol; 2021 Mar; 17(7):795-805. PubMed ID: 33541123
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic variants in genes of tricarboxylic acid cycle key enzymes are associated with prognosis of patients with non-small cell lung cancer.
    Guo X; Li D; Wu Y; Chen Y; Zhou X; Wang X; Huang X; Li X; Yang H; Xing J
    Lung Cancer; 2015 Feb; 87(2):162-8. PubMed ID: 25576295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of EpCAM gene and prognosis for non-small-cell lung cancer in Han Chinese.
    Yang Y; Fei F; Song Y; Li X; Zhang Z; Fei Z; Su H; Wan S
    Cancer Sci; 2014 Jan; 105(1):89-96. PubMed ID: 24304228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KRAS genetic variant as a prognostic factor for recurrence in resectable non-small cell lung cancer.
    Sullivan I; Salazar J; Arqueros C; Andrés M; Sebio A; Majem M; Szafranska J; Martínez E; Páez D; López-Pousa A; Baiget M; Barnadas A
    Clin Transl Oncol; 2017 Jul; 19(7):884-890. PubMed ID: 28150169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer.
    Yoon KA; Yoon H; Park S; Jang HJ; Zo JI; Lee HS; Lee JS
    J Thorac Cardiovasc Surg; 2012 Oct; 144(4):794-807. PubMed ID: 22818121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of polymorphisms at HORMAD2 and prognosis in advanced non-small-cell lung cancer patients.
    Zhang K; Tang S; Cao S; Hu L; Pan Y; Ma H; Guo X; Wu S; Shen H; Hu Z
    Cancer Epidemiol; 2014 Aug; 38(4):414-8. PubMed ID: 24797335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of thymidylate synthase gene polymorphism on the response to chemotherapy and clinical outcome of non-small cell lung cancer patients.
    Dong H; Bao D; Guo X; Hu J; Li X; Wan S; Xing J
    Tumour Biol; 2015 Sep; 36(9):7151-7. PubMed ID: 25877757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms of HIF1A gene are associated with prognosis of early stage non-small-cell lung cancer patients after surgery.
    Liu B; Liu Q; Song Y; Li X; Wang Y; Wan S; Zhang Z; Su H
    Med Oncol; 2014 Apr; 31(4):877. PubMed ID: 24567056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma.
    Yeo MK; Choi SY; Seong IO; Suh KS; Kim JM; Kim KH
    Hum Pathol; 2017 Oct; 68():103-111. PubMed ID: 28851662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional polymorphisms of circadian positive feedback regulation genes and clinical outcome of Chinese patients with resected colorectal cancer.
    Zhou F; He X; Liu H; Zhu Y; Jin T; Chen C; Qu F; Li Y; Bao G; Chen Z; Xing J
    Cancer; 2012 Feb; 118(4):937-46. PubMed ID: 21773969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor receptor 2 gene polymorphisms as predictors for tumor recurrence and overall survival in non-small-cell lung cancer.
    Uzunoglu FG; Kaufmann C; Wikman H; Güngör C; Bohn BA; Nentwich MF; Reeh M; Pantel K; Bockhorn M; Kutup A; Mann O; Izbicki JR; Vashist YK
    Ann Surg Oncol; 2012 Jul; 19(7):2159-68. PubMed ID: 22395975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variations in monocarboxylate transporter genes as predictors of clinical outcomes in non-small cell lung cancer.
    Guo X; Chen C; Liu B; Wu Y; Chen Y; Zhou X; Huang X; Li X; Yang H; Chen Z; Xing J
    Tumour Biol; 2015 May; 36(5):3931-9. PubMed ID: 25578492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A potentially functional polymorphism in ABCG2 predicts clinical outcome of non-small cell lung cancer in a Chinese population.
    Sun J; Zhu M; Shen W; Wang C; Dai J; Xu L; Jin G; Hu Z; Ma H; Shen H
    Pharmacogenomics J; 2017 Jun; 17(3):280-285. PubMed ID: 26951883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional FLT1 Genetic Variation is a Prognostic Factor for Recurrence in Stage I-III Non-Small-Cell Lung Cancer.
    Glubb DM; Paré-Brunet L; Jantus-Lewintre E; Jiang C; Crona D; Etheridge AS; Mirza O; Zhang W; Seiser EL; Rzyman W; Jassem J; Auman T; Hirsch FR; Owzar K; Camps C; Dziadziuszko R; Innocenti F
    J Thorac Oncol; 2015 Jul; 10(7):1067-75. PubMed ID: 26134224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TSC2 genetic variant and prognosis in non-small cell lung cancer after curative surgery.
    Lee YH; Do SK; Lee SY; Kang HG; Choi JE; Hong MJ; Lee JH; Lee EB; Jeong JY; Shin KM; Lee WK; Seok Y; Cho S; Yoo SS; Lee J; Cha SI; Kim CH; Jheon S; Park JY
    Thorac Cancer; 2019 Feb; 10(2):335-340. PubMed ID: 30585697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of the combination of glucose transporter 1 and ATP citrate lyase in node-negative patients with non-small lung cancer.
    Osugi J; Yamaura T; Muto S; Okabe N; Matsumura Y; Hoshino M; Higuchi M; Suzuki H; Gotoh M
    Lung Cancer; 2015 Jun; 88(3):310-8. PubMed ID: 25837797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.